Celltrion, Inc. Stock
Stocks
A068270
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Korea S.E.
2026-08-25
|
5-day change | 1st Jan Change | ||
| 189,600.00 KRW | -2.27% |
|
-3.02% | +9.99% |
| 08-25 | Celltrion Launches Omlyclo 300 Mg Strength In Key European Markets | CI |
| 08-23 | Celltrion Submits Marketing Application for Keytruda Biosimilar in South Korea | MT |
| Market Cap | 45,912B 33.23B 28.52B 26.71B 24.45B 46.07B 3,174B 46.2B 316B 124B 1,600B 125B 122B 5,294B | P/E 2026 * |
29.1x | P/E 2027 * | 25.2x |
|---|---|---|---|---|---|
| Enterprise Value | 48.11B 34.82M 29.89M 27.98M 25.62M 48.27M 3.33B 48.41M 331M 130M 1.68B 131M 128M 5.55B | EV / Sales 2026 * |
8.78x | EV / Sales 2027 * | 7.52x |
| Free-Float |
60.59% | Yield 2026 * |
0.4% | Yield 2027 * | 0.43% |
| 1 day | -2.27% | ||
| 1 week | -3.02% | ||
| Current month | +1.55% | ||
| 1 month | +6.76% | ||
| 3 months | +0.19% | ||
| 6 months | -18.58% | ||
| Current year | +9.99% |
| 1 week | 187,600 |  | 202,000 |
| 1 month | 175,800 | | 212,000 |
| Current year | 158,500 | | 239,047.62 |
| 1 year | 158,500 | | 239,047.62 |
| 3 years | 114,250.83 | | 239,047.62 |
| 5 years | 114,250.83 | | 247,058.06 |
| 10 years | 64,487.59 | | 325,235.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 2015-03-19 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 2021-03-25 |
Hyeok-Jae Lee
PSD | President | 50 | 2026-02-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 68 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 2005-03-31 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/16/26 | Sell | 500 | 0.0002% | |||
| 1/16/26 | Sell | 1,000 | 0.0004% | |||
| 1/16/26 | Sell | 1,000 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.27% | -3.02% | +14.22% | +51.50% | 33.48B | |
| +0.10% | +0.44% | +2.80% | +24.32% | 50.96B | |
| +2.65% | +4.45% | +481.36% | +567.32% | 46.18B | |
| +0.33% | +2.47% | +38.97% | +19.80% | 43.04B | |
| -0.88% | +0.90% | +24.11% | +87.74% | 42.73B | |
| -1.21% | -0.17% | +29.16% | +135.38% | 17.28B | |
| -0.36% | -2.14% | - | - | 16.43B | |
| +0.25% | +0.25% | +12.03% | +30.68% | 14.73B | |
| +0.44% | +1.70% | +82.07% | +47.92% | 14.09B | |
| +0.47% | -2.61% | -2.46% | -33.79% | 13.03B | |
| Average | -0.05% | +0.05% | +75.81% | +103.43% | 29.2B | |
| Weighted average by Cap. | +0.06% | +0.43% | +99.30% | +133.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,480B 3.97B 3.4B 3.19B 2.92B 5.5B 379B 5.51B 37.75B 14.76B 191B 14.89B 14.57B 632B | 6,294B 4.56B 3.91B 3.66B 3.35B 6.31B 435B 6.33B 43.35B 16.95B 219B 17.1B 16.73B 726B |
| Net income | 1,511B 1.09B 939M 879M 805M 1.52B 104B 1.52B 10.41B 4.07B 52.64B 4.11B 4.02B 174B | 1,763B 1.28B 1.1B 1.03B 939M 1.77B 122B 1.77B 12.15B 4.75B 61.43B 4.79B 4.69B 203B |
| Net Debt | 2,199B 1.59B 1.37B 1.28B 1.17B 2.21B 152B 2.21B 15.14B 5.92B 76.6B 5.97B 5.85B 254B | 1,409B 1.02B 875M 820M 750M 1.41B 97.4B 1.42B 9.71B 3.79B 49.09B 3.83B 3.75B 162B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-27 | ₩191,300.00 | -1.09% | 255,697 |
| 26-08-26 | ₩193,400.00 | +2.00% | 326,386 |
| 26-08-25 | ₩189,600.00 | -2.27% | 358,412 |
| 26-08-24 | ₩194,000.00 | +0.88% | 314,860 |
| 26-08-21 | ₩192,300.00 | -0.93% | 354,956 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- A068270 Stock
Select your edition
All financial news and data tailored to specific country editions
